Crossmark

Long-term comparison of renal and metabolic outcomes after sodium–glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes

Crossref DOI link: https://doi.org/10.1186/s12916-024-03483-z

Published Online: 2024-07-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sohn, Minji

Nam, Seoungyeon

Nauck, Michael A.

Lim, Soo https://orcid.org/0000-0002-4137-1671
License Information

Text and Data Mining valid from 2024-07-02

Version of Record valid from 2024-07-02
More Information

Article History

Received: 13 November 2023

Accepted: 13 June 2024

First Online: 2 July 2024

Declarations

:

: This study was approved by an independent Ethics Committee/Institutional Review Board of the Seoul National University Bundang Hospital (B-2103–675-103). The requirement for informed consent was waived.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below